Gregory Meyers

Mr. Meyers is currently the Chief Operating Officer (COO) of NEXTMolecular Analytics. Previously, he was Vice President of DNA Services at American International Biotechnology, LLC., in Richmond, VA. He was responsible for oversight and direction of, among other labs, the clinical molecular diagnostic lab where he designed and led the development and validation of several next generation sequencing diagnostic assays used for clinical practice. Prior to that, he served as a Senior Systems Analyst for Analytic Services, Inc. (ANSER), providing advisory and assistance service support to the Department of Defense Transformational Medical Technologies program, serving as a subject matter expert focused mainly on the areas of pathogen identification and characterization and bioinformatics.

Prior to joining ANSER, Mr. Meyers was a Group Leader, DNA Services, Commonwealth Biotechnologies, Inc., where he oversaw laboratory operations and scientific program direction of molecular biology, DNA sequencing, and microbial forensic and diagnostic service areas, and Project Manager, Icoria, Inc. where he was responsible for all project management aspects of $55million agricultural genomics collaboration between Monsanto Inc. and Icoria. Mr. Meyers received his BS degree from Virginia Tech in Biology, with an emphasis on microbiology, and his MS degree from VCU/MCV in Microbiology and Immunology. Mr. Meyers is the author of numerous peer reviewed publications and is a co-inventor on several US patents.